XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Receivables from Stockholder [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 126 $ 568,496 $ (572,599) $ (3,977)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019 125,803        
Share-based compensation expense 344 344
Share-based compensation expense, shares 201        
Exercise of options 3 3
Exercise of options, shares 4        
Sales of common stock $ 17 8,329 8,346
Sales of common stock, shares 17,425        
Net loss (7,238) (7,238)
Ending balance, value at Jun. 30, 2020 $ 143 577,172 (579,837) (2,522)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020 143,433        
Beginning balance, value at Dec. 31, 2019 $ 126 568,496 (572,599) (3,977)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019 125,803        
Ending balance, value at Dec. 31, 2020 $ 153 601,224 (6,135) (586,233) $ 9,009
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2020 152,926       152,926
Beginning balance, value at Mar. 31, 2020 $ 131 570,128 (577,533) $ (7,274)
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2020 130,878        
Share-based compensation expense 187 187
Share-based compensation expense, shares 201        
Exercise of options 3 3
Exercise of options, shares 4        
Sales of common stock $ 12 6,854 6,866
Sales of common stock, shares 12,350        
Net loss (2,304) (2,304)
Ending balance, value at Jun. 30, 2020 $ 143 577,172 (579,837) (2,522)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020 143,433        
Beginning balance, value at Dec. 31, 2020 $ 153 601,224 (6,135) (586,233) $ 9,009
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020 152,926       152,926
Share-based compensation expense $ 2 9,533 $ 9,535
Share-based compensation expense, shares 2,140        
Exercise of options $ 1 2,509 2,510
Exercise of options, shares 1,340        
Sales of common stock $ 8 122,893 6,135 129,036
Sales of common stock, shares 7,554        
Net loss (21,193) (21,193)
Ending balance, value at Jun. 30, 2021 $ 164 736,159 (607,426) $ 128,897
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2021 163,960       163,960
Beginning balance, value at Mar. 31, 2021 $ 158 660,267 (592,464) $ 67,961
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2021 157,952        
Share-based compensation expense $ 2 7,895 7,897
Share-based compensation expense, shares 1,772        
Exercise of options 429 429
Exercise of options, shares 269        
Sales of common stock $ 4 67,568 67,572
Sales of common stock, shares 3,967        
Net loss (14,962) (14,962)
Ending balance, value at Jun. 30, 2021 $ 164 $ 736,159 $ (607,426) $ 128,897
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2021 163,960       163,960